GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dr Reddy's Laboratories Ltd (NYSE:RDY) » Definitions » Cash Receipts from Tax Refunds

Dr Reddy's Laboratories (Dr Reddy's Laboratories) Cash Receipts from Tax Refunds


View and export this data going back to 2001. Start your Free Trial

What is Dr Reddy's Laboratories Cash Receipts from Tax Refunds?

Cash Receipts from Tax Refunds only applicable to companies reporting Cash Flow from Operations in direct method.

Dr Reddy's Laboratories (Dr Reddy's Laboratories) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dr Reddy's Laboratories Ltd (NYSE:RDY) » Definitions » Cash Receipts from Tax Refunds
Comparable Companies
BOM:532321 BOM:543904 NSE:DIVISLAB NSE:TORNTPHARM BOM:500257 NSE:AUROPHARMA NSE:ALKEM BOM:524494 BOM:532331 BOM:532296 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA TSE:4507 VTRS NBIX XSWX:SDZ
Traded in Other Exchanges
DRREDDY:India 500124:India RDDA:Germany RDDA:Germany R1DY34:Brazil
Address
8-2-337, Road No. 3, Banjara Hills, Hyderabad, TG, IND, 500 034
Website
https://www.drreddys.com
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (22% of its generics sales), Russia (12%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.